## HIMS: Hims & Hers Health, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -5.2% below STRENGTH zone (4.0-10.0%); PEG 2.07 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($31.10)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $48 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.00M) |
| Sells | 17 ($8.92M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 67.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- JPMORGAN CHASE & CO: 16.2% (+1198.1%)
- Blackrock Inc.: 11.5% (+1.6%)
- Vanguard Group Inc: 8.9% (+4.5%)
- Capital World Invest: 8.6% (+1.2%)
- Farallon Capital Man: 4.9% (+30.8%)

### Key Risks

1. High beta (2.41) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Insider selling cluster: $8.9M in recent transactions.
3. Premium valuation (P/E 54x, PEG 2.1x) vulnerable to multiple compression.
4. High short interest (36.6%, 2.6 days to cover): squeeze risk or crowded bearish bet.
5. Long-term trend broken: trading 22.4% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.07 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 26%). Insider selling cluster ($8.9M in 90 days), potential headwind. Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.1B |
| Beta | 2.41 |
| 52W Range | $23.97 - $72.98 |
| Short Interest | 36.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.07 |
| Forward P/E | 54.0 |
| Current P/E | 74.4 |
| YoY Growth | 37.8% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from -2.7% to -5.2% (-2.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 9.2pp (needs >4.0% for momentum thesis). AM_20 at -5.0% indicates price below own 20MA trend. Underperforming sector by 5.2pp, stock-specific weakness. Below SMA200 (0.78x), long-term trend not supportive. RSI neutral at 40. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.25% (CS: 10) | Weak |
| RSI_14 | 40.5 | Neutral |
| MACD Histogram | 0.04 | Bullish |
| vs SMA20 | 0.950x | Below |
| vs SMA50 | 0.843x | Below |
| vs SMA200 | 0.776x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $35.54
- **Stop Loss:** $31.10 (12.5% risk)
- **Target:** $39.98 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 270
- **Position Value:** $9,595.80
- **Portfolio %:** 9.60%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-23 (Est: $0.05)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.10 | $0.06 | -41.0% |
| 2025Q2 | $0.16 | $0.17 | +3.2% |
| 2025Q1 | $0.12 | $0.20 | +65.0% |
| 2024Q4 | $0.11 | $0.11 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*